Literature DB >> 29725976

Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Laísa Simakawa Jimenez1, Fábio Henrique Mendonça Chaim1, Felipe David Mendonça Chaim1, Murillo Pimentel Utrini1, Martinho Antonio Gestic1, Elinton Adami Chaim1, Everton Cazzo2.   

Abstract

BACKGROUND: The influence of post-surgical weight regain on the course of non-alcoholic fatty liver disease (NAFLD) is unclear.
OBJECTIVE: To evaluate the influence of weight regain on the NAFLD assessed by means of a non-invasive score after Roux-en-gastric bypass (RYGB) over a 3-year period.
METHODS: This is a prospective observational cohort study which evaluated individuals who underwent RYGB. Comparisons were made between the periods immediately before surgery and 12, 24, and 36 months following surgery. Liver disease was estimated by means of the NAFLD fibrosis score. Individuals were classified into three categories according to weight regain status: (1) no weight regain, (2) expected weight regain (regain less or equal than 20% of the maximal weight lost), (3) obesity recidivism (regain above 20% of the maximal weight lost).
RESULTS: Of 90 patients analyzed after 3 years of surgery, 35.6% presented obesity recidivism and 28.8% of the expected regain; 35.6% presented no regain. There was no difference in baseline fibrosis score between groups; at 3 years, the score observed in the relapse group was significantly higher than that observed in the other two groups (p = 0.015). The percent variation of the fibrosis score was significantly higher in the recidivism group (+ 11.8 ± 77.2%) than in the expected regain (- 45.6 ± 64.5%) and no regain (- 37.8 ± 63.2%) groups (p = 0.013).
CONCLUSION: Long-term significant post-RYGB weight regain is associated with a significantly attenuated improvement of NAFLD evaluated by means of liver fibrosis score.

Entities:  

Keywords:  Bariatric surgery; Fatty liver; Gastric bypass; Obesity; Weight loss

Mesh:

Year:  2018        PMID: 29725976     DOI: 10.1007/s11695-018-3286-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

2.  Control of hypertension after roux-en-y gastric bypass among obese diabetic patients.

Authors:  Everton Cazzo; Martinho Antonio Gestic; Murillo Pimentel Utrini; Ricardo Rossetto Machado; José Carlos Pareja; Elinton Adami Chaim
Journal:  Arq Gastroenterol       Date:  2014 Jan-Mar

3.  Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

Review 4.  Weight regain after gastric bypass: etiology and treatment options.

Authors:  Almantas Maleckas; Rita Gudaitytė; Rūta Petereit; Linas Venclauskas; Džilda Veličkienė
Journal:  Gland Surg       Date:  2016-12

5.  Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.

Authors:  Andrew A Taitano; Michael Markow; Jon E Finan; Donald E Wheeler; John Paul Gonzalvo; Michel M Murr
Journal:  J Gastrointest Surg       Date:  2014-12-24       Impact factor: 3.452

Review 6.  Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.

Authors:  Everton Cazzo; José Carlos Pareja; Elinton Adami Chaim
Journal:  Sao Paulo Med J       Date:  2017-05-29       Impact factor: 1.044

Review 7.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

Review 8.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.

Authors:  Rajasekhara R Mummadi; Krishna S Kasturi; Swapna Chennareddygari; Gagan K Sood
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Long-term weight regain after gastric bypass: a 5-year prospective study.

Authors:  Daniéla Oliveira Magro; Bruno Geloneze; Regis Delfini; Bruna Contini Pareja; Francisco Callejas; José Carlos Pareja
Journal:  Obes Surg       Date:  2008-04-08       Impact factor: 4.129

View more
  7 in total

1.  Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study.

Authors:  Tiago Bezerra de Freitas Diniz; Rafael Nascimento de Jesus; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

Review 2.  Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.

Authors:  Iraklis Perysinakis; Harilaos C Pappis; Elias Margaris
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

Review 3.  Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.

Authors:  Miller Barreto de Brito E Silva; Francisco Tustumi; Antonio Afonso de Miranda Neto; Anna Carolina Batista Dantas; Marco Aurélio Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2021-04-13       Impact factor: 4.129

4.  Relationship among Self-Efficacy Expectations, Locus of Control, and Attributions in Bariatric Patients.

Authors:  Carla Ugarte; Álvaro Quiñones; Luis Angel Saúl
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

5.  A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease.

Authors:  Xin Chu; Kelsey Karasinski; Sean Donellan; Scott Kaniper; G Craig Wood; Weixing Shi; Michael A Edwards; Rohit Soans; Christopher D Still; Glenn S Gerhard
Journal:  Langenbecks Arch Surg       Date:  2019-12-11       Impact factor: 3.445

6.  Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease.

Authors:  Mi Na Kim; Kyungdo Han; Juhwan Yoo; Yeonjung Ha; Young Eun Chon; Ju Ho Lee; Tracey G Simon; Andrew T Chan; Seong Gyu Hwang
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

7.  Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.

Authors:  Luyang Wei; Mengyi Li; Na Zeng; Yang Liu; Rixing Bai; Nengwei Zhang; Jinghai Song; Pin Zhang; Qiyuan Yao; Zhenghan Yang; Xinyan Zhao; Yun Zhang; Peng Zhang; Zhongtao Zhang
Journal:  BMC Surg       Date:  2021-06-24       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.